Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias (Q44470510)

3 December 2017

Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias (English)

1 reference

hypertrophic cardiomyopathy

3 December 2017

1 reference

Hidenobu Terai

1

1 reference

3 December 2017

Masami Shimizu

2

1 reference

3 December 2017

Hidekazu Ino

3

1 reference

3 December 2017

Masato Yamaguchi

4

1 reference

3 December 2017

Kenshi Hayashi

5

1 reference

3 December 2017

Kenji Sakata

6

1 reference

3 December 2017

Masaru Kiyama

7

1 reference

3 December 2017

Tatsumi Hayashi

8

1 reference

3 December 2017

Masaru Inoue

9

1 reference

3 December 2017

Junichi Taki

10

1 reference

3 December 2017

Hiroshi Mabuchi

11

1 reference

3 December 2017

language of work or name

1 reference

1 May 2003

1 reference

Journal of Nuclear Cardiology

3 December 2017

1 reference

3 December 2017

10

1 reference

3 December 2017

3

1 reference

3 December 2017

304-310

1 reference

https://scigraph.springernature.com/pub.10.1016/s1071-3581(03)00362-3

3 December 2017

0 references

cites work

Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death

1 reference

12 December 2020

Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Sudden cardiac death in heart failure. The role of abnormal repolarization

1 reference

12 December 2020

Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.

1 reference

12 December 2020

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

12 December 2020

Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations

1 reference

12 December 2020

Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.

1 reference

12 December 2020

Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps.

1 reference

12 December 2020

Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart

1 reference

12 December 2020

Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy

1 reference

12 December 2020

Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy

1 reference

12 December 2020

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

1 reference

12 December 2020

Hypertrophie cardiomyopathy: A discussion of nomenclature

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy

1 reference

12 December 2020

Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy

1 reference

12 December 2020

Physiological fluctuation of the human left ventricle sympathetic nervous system assessed by iodine-123-MIBG.

1 reference

12 December 2020

Hypertrophic cardiomyopathy

1 reference

12 December 2020

Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy

1 reference

12 December 2020

Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic

1 reference

12 December 2020

Adrenergic effects on reentrant ventricular rhythms in subacute myocardial infarction

1 reference

12 December 2020

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

12 December 2020

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

12 December 2020

Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication

1 reference

12 December 2020

Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects

1 reference

12 December 2020

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients

1 reference

12 December 2020

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

1 reference

12 December 2020

Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Severity of arrhythmias and extent of hypertrophy in hypertrophic cardiomyopathy

1 reference

12 December 2020

Automatic quantification of ejection fraction from gated myocardial perfusion SPECT.

1 reference

12 December 2020

10.1016/S1071-3581(03)00362-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference